Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Grant_Pickering
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:developedBy |
conjugate vaccines
|
| gptkbp:focusesOn |
infectious diseases
vaccines |
| gptkbp:foundedIn |
2013
|
| gptkbp:founder |
William J. Newell
|
| gptkbp:fundedBy |
gptkb:Abingworth
gptkb:Pivotal_bioVenture_Partners CTI Life Sciences Fund Frazier Healthcare Partners Longitude Capital Roche Venture Fund |
| gptkbp:hasProductCandidate |
vaccine
|
| gptkbp:headquartersLocation |
gptkb:Foster_City,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
SutroVax
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:usesTechnologyFrom |
gptkb:Sutro_Biopharma
|
| gptkbp:bfsParent |
gptkb:Vaxcyte
gptkb:South_San_Francisco,_California,_USA |
| gptkbp:bfsLayer |
7
|